The Pharmaceutical Marketing Group | The industry Meeting Point

Click here - to use the wp menu builder

TPMG FEATURED ARTICLES

Alzheimer’s Researchers Release Free Apps to Track Memory and Cognition

Margaretta Colangelo - July 9, 2021

How Dogs Could Help Us Discover How To Increase Healthy Lifespan in Humans

Margaretta Colangelo - June 30, 2021

COVID-19 Vaccines Global Forum Publishes 16 Recommendations

Margaretta Colangelo - June 30, 2021

AI-Enabled Doctors Will Specialize In Longevity Medicine

Margaretta Colangelo - June 30, 2021

Read more from our featured authors: Natalie Yeadon – Margaretta Colangelo

COVID-19 Statics

All countries

197,619,939

Total confirmed cases

Updated on July 30, 2021 3:37 pm

COVID-19 Statics

All countries

4,218,872

Total deaths

Updated on July 30, 2021 3:37 pm

COVID-19 Statics

All countries

176,977,627

Total recovered

Updated on July 30, 2021 3:37 pm

Look Who’s On the Move!Admin - July 30, 2021

Merck Announces Appointment of Cristal N. Downing as Chief...

Look Who’s On the Move!Admin - July 29, 2021

Prokarium Appoints Uz Stammberger as Chief Medical Officer to...

Look Who’s On the Move!Admin - July 29, 2021

Gregory K. Palm Joins Olatec Therapeutics’ Board of Directors

Look Who’s On the Move!Admin - July 29, 2021

Adagio Therapeutics Appoints Leading Pharmaceutical and Regulatory Executives to...

Must Read

2019 AuthorsSubba Rao Chaganti -

Addition by Subtraction

Addition by Subtraction? Sounds paradoxical? Unbelievable? Consider what Lao Tzu, the great Chinese philosopher said 2,500 years ago. Here is the essence of what he said: To attain knowledge, add things everyday. To attain wisdom, subtract things everyday. Profit comes from what is there, and usefulness comes from what is not there.

Regulatory AffairsAdmin - July 29, 2021

FDA Accepts Application for Genentech’s Faricimab for the Treatment...

Regulatory AffairsAdmin - July 29, 2021

Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA...

Regulatory AffairsAdmin - July 29, 2021

Dicerna Announces FDA Clearance of Investigational New Drug (IND)...

Regulatory AffairsAdmin - July 28, 2021

Abata Therapeutics Strengthens Board of Directors

EDITOR´S PICK

Editor´s PickJuly 29, 2021

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

Editor´s PickJuly 23, 2021

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents...

Editor´s PickJuly 21, 2021

Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

Editor´s PickJuly 20, 2021

Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate...

Editor´s PickJuly 20, 2021

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

Editor´s PickJuly 20, 2021

Almost 70% of Doctors Say COVID-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows

Editor´s PickJuly 19, 2021

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD

Editor´s PickJuly 12, 2021

Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of...

INDUSTRY NEWS

Industry NewsJuly 30, 2021

UK Biomanufacturing Team to Spearhead Development of Advanced Controls to Accelerate Drug and Vaccine Manufacturing

Industry NewsJuly 30, 2021

Keystone Bio Advances a More Complete Explanation of Porphyromonas Gingivalis Toxic Virulence Factors as Major Driver of Sporadic Alzheimer’s and Chronic Inflammation

Industry NewsJuly 30, 2021

Better Therapeutics and Colorado Prevention Center Clinical Research Launch Real-World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

Industry NewsJuly 30, 2021

Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of...

Industry NewsJuly 29, 2021

Alzamend Neuro Receives FDA “Study May Proceed” Letter for Phase 1 Clinical Study Under Its Investigational New Drug Application for AL001 for Dementia Related...

Industry NewsJuly 29, 2021

Data for Genentech’s Evrysdi (risdiplam) Published in New England Journal of Medicine Shows Significant Improvement in Survival and Motor Milestones in Babies With Type...

Industry NewsJuly 29, 2021

Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1

Industry NewsJuly 29, 2021

CytRx Highlights Preliminary Results of Cohort C of QUILT 88, a Phase 2 Pancreatic Cancer Trial That Includes Aldoxorubicin, Expected to be Released in...

PRESS RELEASES

Press ReleasesJuly 14, 2021

PRESS RELEASE: Impetus Digital’s new eBook, The Complete Guide to Virtualizing In-person Meetings, is now available!

Press ReleasesJune 29, 2021

The future of Clinical Trials

NEWSLETTERS

Check out our Newsletter page - choose the one that fits your needs!

LOOK WHO IS ON THE MOVE

Don't be the last one to know. Subscribe to our weekly newsletter.

EDITOR´S PICK

Receive the best information to your inbox.

FEATURED WRITER

Read what the top minds in pharma have to say!

WEBINARS & WHITEPAPERS

Welcome to the new marketing jungle

Admin - April 23, 2021

The path to market for digital health solutions

Admin - April 23, 2021

BMS, GSK and Astellas join OKRA to discuss the answer to uncertainty

Admin - April 23, 2021

Digital companions – the future of holistic patient support

Admin - April 22, 2021

5 changes you have to make right now: Accelerating HCP engagement post-crisis

Admin - April 22, 2021